Biohaven’s Troriluzole Joins Long List of Failed Alzheimer’s Drugs
The chances of getting a cure for Alzheimer’s disease took one more hit as another Alzheimer’s trial bit the dust. On January 18th, Biohaven Pharmaceuticals announced that its drug troriluzole, …
Read More